Press release - 10/07/2009 How to make tumour cells undergo suicide? How to make tumour cells undergo suicide? The pathologist Dr. Wilfried Roth was awarded the Rudolf Virchow Prize and a cheque of 5000 euros for his work on inducing apoptosis in tumour cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-to-make-tumour-cells-undergo-suicide
Press release - 09/07/2009 Antitrust: European Commission: shortcomings in pharmaceutical sector require further action Der Markteintritt von Generika verzögert sich und die Anzahl neuartiger Arzneimittel auf dem Markt ist rückläufig. Zu diesem Ergebnis kommt die Europäische Kommission in ihrem Abschlussbericht über den Wettbewerb im Arzneimittelsektor. Die Sektoruntersuchung deutet darauf hin dass auch bestimmte Unternehmenspraktiken für diese Entwicklung verantwortlich sind ohne indessen auszuschließen dass mitunter weitere Faktoren wie unzureichende…https://www.gesundheitsindustrie-bw.de/en/article/press-release/antitrust-european-commission-shortcomings-in-pharmaceutical-sector-require-further-action
Article - 09/07/2009 Four Nobel Prizes for a chicken virus The Rous sarcoma virus (RSV) was the starting point of the discovery that cancer can be brought on by infections. The enzyme “reverse transcriptase”, which led to a rethinking and technological revolution in the field of molecular biology, was discovered in this retrovirus along with oncogenes that led to a completely new concept of cancer development in molecular genetics and eventually to the development of a new generation of cancer…https://www.gesundheitsindustrie-bw.de/en/article/news/four-nobel-prizes-for-a-chicken-virus
Article - 09/07/2009 Innovations for medical technology - the MicroMountains iNNOVATION fORUM The second iNNOVATION fORUM for medical technology, held in Tuttlingen on June 23rd, once again enabled companies to find out about promising product ideas. The MicroMountains Network technology initiative could not have chosen a more suitable location than the city of Tuttlingen, well-known as a “world centre of medical technology”. As the biologisation of medical technology is becoming more and more common, researchers at the NMI in Reutlingen…https://www.gesundheitsindustrie-bw.de/en/article/news/innovations-for-medical-technology-the-micromountains-innovation-forum
Press release - 09/07/2009 Marcus Groettrup: Discovery in the kingdom of cells Prof. Marcus Groettrup has been closely investigating the daily defence battle of the human immune system for a number of years. The researcher from Constance has now found a substance that has the potential to revolutionise the treatment of rheumatism.https://www.gesundheitsindustrie-bw.de/en/article/press-release/marcus-groettrup-discovery-in-the-kingdom-of-cells
Article - 08/07/2009 The small directors in the cell They have been overlooked for quite a long time, despite the fact that they constitute a large part of the genetic material in many organisms. Biologists are gradually discovering that bacteria as well as human and plant cells need them for proper function. Prof. Dr. Wolfgang Hess and his team at the Institute of Biology III at the University of Freiburg have been focusing on them for a number of years – we are referring to non-coding RNAs. The…https://www.gesundheitsindustrie-bw.de/en/article/news/the-small-directors-in-the-cell
Press release - 07/07/2009 Investment in the future: ILM receives funds for the purchase of equipment The Ulm-based Institute for Laser Technologies in Medicine and Metrology (ILM) has received a 335,000 euro injection in 2009 through the German government’s Future Investment Programme (Economic Stimulus Packet II), according to the Baden-Württemberg Minister of Economic Affairs Ernst Pfister. The funds, 75 per cent of which are provided by the German government and 25 per cent by the state of Baden-Württemberg, will be used for the modernisation…https://www.gesundheitsindustrie-bw.de/en/article/press-release/investment-in-the-future-ilm-receives-funds-for-the-purchase-of-equipment
Press release - 03/07/2009 Green Stem Cells in a Moss Although every cell of a living organism contains essentially the same genes, most animals and plants are composed of a huge variety of different cell types with special functions: Humans can’t think with their skin, and roses can’t flower with their roots. An Israeli-German Research Consortium has discovered what makes the difference in a moss.https://www.gesundheitsindustrie-bw.de/en/article/press-release/green-stem-cells-in-a-moss
Press release - 03/07/2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a collaboration to fight Alzheimer`s disease Boehringer Ingelheim and Vitae Pharmaceuticals Inc. announced today that they have entered into a significant worldwide collaboration to research and develop beta-secretase BACE inhibitors for the treatment of Alzheimers disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/boehringer-ingelheim-and-vitae-pharmaceuticals-announce-a-collaboration-to-fight-alzheimer-s-disease
Press release - 02/07/2009 Phenex receives 1.4 Mio Euro BioChance Grant Phenex Pharmaceuticals AG today announced the approval of a 1.4 Mio Euro grant from the KMU-Innovativ-BioChance program of the German Ministry for Education and Research (BMBF). The grant will support preclinical research & development of Farnesoid X Receptor (FXR) ligands for medical applications beyond Type 2 Diabetes.https://www.gesundheitsindustrie-bw.de/en/article/press-release/phenex-receives-1-4-mio-euro-biochance-grant
Article - 02/07/2009 A virus that hides while it waits for an opportunity to replicate Thomas Mertens, Medical Director of the Institute of Virology in Ulm, has a strong scientific and clinical interest in the human cytomegalovirus (HCMV), a big virus with a big impact which, despite its size, is overshadowed by known viruses such as the HI virus that is the object of research for Mertens’ colleagues. HCMV research is a challenging area where quick successes are rare.https://www.gesundheitsindustrie-bw.de/en/article/news/a-virus-that-hides-while-it-waits-for-an-opportunity-to-replicate
Article - 01/07/2009 KIT - Competence in bioprocess engineering The purification of microbially produced substances such as proteins and polysaccharides and their separation from or release from within the cell are complex tasks in the field of biotechnology. The Bioprocess Engineering department of the Institute of Process Engineering in the Life Sciences TH deals with the development of integrated bioprocesses and is also involved in the separation of biopolymers.https://www.gesundheitsindustrie-bw.de/en/article/news/kit-competence-in-bioprocess-engineering
Press release - 30/06/2009 Gentle rather than radical: ways to improve the treatment of autoimmune diseases Autoimmune diseases are usually treated with drugs that block the entire immune system rendering the body very susceptible to all kinds of infections. A team of Constance researchers under the leadership of Prof. Marcus Groettrup has developed a treatment method that only targets part of the immune system and is therefore far better tolerated by patients. https://www.gesundheitsindustrie-bw.de/en/article/press-release/gentle-rather-than-radical-ways-to-improve-the-treatment-of-autoimmune-diseases
Press release - 30/06/2009 febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment In the near future, Next-Generation Sequencing technologies will lead to a rising number of completed genomes of model organisms and other species of interest, as demonstrated by the updated mouse genome. This accelerated development will generate a variety of tools available in the short term for the application of the new data into experiments. febit’s technology enables the conversion of new sequence data into biochips for gene expression…https://www.gesundheitsindustrie-bw.de/en/article/press-release/febit-first-to-offer-newly-published-mouse-genome-on-a-chip-for-dna-rna-detection-and-enrichment
Article - 30/06/2009 More targeted treatment of the brain network “Casting out the demons with the ruler of the demons” – is what the majority of neuroactive drugs still do. A group under the leadership of Dr. Ralf Meyer at the University Medical Centre in Freiburg is investigating why substances used to treat epilepsy or depression have a negative effect on many patients. Their research shows that the drugs interact with the hormonal system, resulting in undesired side effects. Meyer and his team of…https://www.gesundheitsindustrie-bw.de/en/article/news/more-targeted-treatment-of-the-brain-network
Press release - 30/06/2009 The genome as glue Many engineers who need to work with structured materials with small pores most likely dream of a glue that not only holds the tiny particles together, but also automatically brings them into contact at the correct distance from each other. Scientists under the leadership of Prof. Clemens Richert and Prof. Stefan Bräse at the Karlsruhe Institute of Technology (KIT) have now developed a “bioglue” using a process that is summarised in the journal…https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-genome-as-glue
Press release - 29/06/2009 From spinal cord to bowel – pragmatic drug development in Tübingen Tübingen-based Synovo GmbH seeks partners to develop drugs for chronic inflammatory bowel diseases. https://www.gesundheitsindustrie-bw.de/en/article/press-release/from-spinal-cord-to-bowel-pragmatic-drug-development-in-tuebingen
Press release - 29/06/2009 Uncovering how cells cover gaps Researchers at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, came a step closer to understanding how cells close gaps not only during embryonic development but also during wound healing. Their study, published this week in the journal Cell, uncovers a fundamental misconception in the previous explanation for a developmental process called dorsal closure.https://www.gesundheitsindustrie-bw.de/en/article/press-release/uncovering-how-cells-cover-gaps
Article - 29/06/2009 Alternative protein structures and breast cancer A single protein can have many variants. This variability is achieved by a process known as splicing which can introduce small modifications into the mRNA transcript of a gene. Prof. Dr. Elmar Stickeler from the University Womens Hospital in Freiburg found that some of these splice variants can also induce cancer. Stickeler and his team are investigating how splicing factors change their target molecules and how this leads to breast cancer. This…https://www.gesundheitsindustrie-bw.de/en/article/news/alternative-protein-structures-and-breast-cancer
Press release - 29/06/2009 Can loss of sense of smell predict Alzheimer’s The first lapses of memory go hand in hand with a loss of the sense of smell: The olfactory centre in the brain of Alzheimer’s patients is wasting away. The olfactory bulb starts to shrink at a very early stage of the disease, at a time when retentiveness is only slightly affected. It is possible to detect the shrinkage of the olfactory bulb with magnetic resonance imaging, as the latest findings by scientists of the Department of Psychiatry at…https://www.gesundheitsindustrie-bw.de/en/article/press-release/can-loss-of-sense-of-smell-predict-alzheimer-s
Press release - 29/06/2009 How can cancer pain be treated effectively? Cancer patients often suffer from severe pain that cannot be treated effectively with traditional drugs. Scientists at the Institute of Pharmacology at the University of Heidelberg have now discovered the potential reason for the severe pain associated with several forms of cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-can-cancer-pain-be-treated-effectively
Press release - 29/06/2009 Vetter strengthens Ravensburg company site Vetter Pharma, a leading provider of aseptically pre-filled injection systems, has completed the installation of several new automatic packaging lines at the company’s new packaging services facility. The packaging facility allows Vetter to package its injection systems for delivery to its clients. The building, which cost 20 million euros to build, has room for 200 employees. https://www.gesundheitsindustrie-bw.de/en/article/press-release/vetter-strengthens-ravensburg-company-site
Press release - 29/06/2009 Research Prize for Clinical Pharmacology in Ulm Julia Kirchheiner, a professor of Clinical Pharmacology at the Institute of Natural Medicine and Clinical Pharmacology, University of Ulm, in Germany, was awarded the Utrecht Award for Excellence in Pharmaceutical Research, 2009. The international prize is awarded once every two years to non-University of Utrecht scientists who have a proven record over years of excellent research vision and leadership of improving drug therapy or safety. https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-prize-for-clinical-pharmacology-in-ulm
Press release - 29/06/2009 New electron microscopy images reveal the assembly of HIV Scientists at the European Molecular Biology Laboratory (EMBL) and the University Clinic Heidelberg, Germany, have produced a three-dimensional reconstruction of HIV (Human Immunodeficiency Virus), which shows the structure of the immature form of the virus at unprecedented detail. Immature HIV is a precursor of the infectious virus, which can cause AIDS. The study, published in the 22-26 June online edition of PNAS, describes how the protein…https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-electron-microscopy-images-reveal-the-assembly-of-hiv
Dossier - 25/06/2009 DNA and RNA replication The replication of the genome is essential for the continuity of life. The molecular mechanism is very similar in all groups of organisms. Although the basics of replication are already well understood, researchers are still focusing on questions relating to DNA replication. These questions not only deal with the understanding of a basic biological process, but also with related medical aspects.https://www.gesundheitsindustrie-bw.de/en/article/dossier/dna-and-rna-replication
Article - 24/06/2009 The initiation of replication – only once, please DNA replication is a critical event in the cell division process. The genetic material must only be replicated once. So, how does a bacterial cell ensure that only one single replication occurs and that the process is not repeated several times? Microbiologists under the leadership of Prof. Dr. Peter Graumann from the Institute of Biology II in Freiburg, in cooperation with international cooperation partners from Paris, have deciphered a…https://www.gesundheitsindustrie-bw.de/en/article/news/the-initiation-of-replication-only-once-please
Press release - 24/06/2009 Artificial liver for drug testing The liver is one of the most important metabolic organs in humans. Johanna Schanz and Heike Mertsching, two scientists from Fraunhofer have developed a model of the liver that is both viable outside the body and suitable for testing drugs. For their work, the two researchers have been awarded the Technology for People award, along with a cheque for 10,000 euros. https://www.gesundheitsindustrie-bw.de/en/article/press-release/artificial-liver-for-drug-testing
Article - 23/06/2009 Hepatitis B and the Münchhausen enzyme Virologists in Prof. Dr. Michael Nassals group at the University Medical Centre in Freiburg are investigating the molecular mechanisms used by the hepatitis B virus to reproduce. The researchers work might in future be able to help the three to four hundred million people worldwide who suffer from chronic hepatitis B infections. https://www.gesundheitsindustrie-bw.de/en/article/news/hepatitis-b-and-the-muenchhausen-enzyme
Press release - 22/06/2009 New important triggers for the migration of cancer cells Embryonic cells and metastasising cancer cells are able to migrate and intrude into other tissues. Investigations of frog embryos have now provided scientists at the Karlsruhe Institute of Technology with the information that a well-known protein, cadherin-11, triggers cell migration. This glycoprotein is also responsible for the defective behaviour of cells that results in prostate cancer and arthritis. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-important-triggers-for-the-migration-of-cancer-cells
Article - 22/06/2009 New method enables the early and reliable detection of metastatic melanoma cells The presence of lymph node metastases has a considerable effect on the prognosis and therapy of patients with malignant melanomas. Therefore the histopathological examination of what are known as sentinel lymph nodes the first lymph nodes that metastasising cancer cells reach is of great importance. However the examination method has its technical limitations where very small metastases are concerned. Professor Dr. Anja Ulmer a dermatologist at…https://www.gesundheitsindustrie-bw.de/en/article/news/new-method-enables-the-early-and-reliable-detection-of-metastatic-melanoma-cells
Press release - 22/06/2009 Many animal experiments are superfluous Researchers at the Esslingen University of Applied Sciences are working on an alternative to the large number of animal experiments that are still being carried out. Researchers under the leadership of Prof. Dr. Bettina Weiß have received a grant from the Landesstiftung Baden-Württemberg foundation for work on this particular research area.https://www.gesundheitsindustrie-bw.de/en/article/press-release/many-animal-experiments-are-superfluous
Press release - 22/06/2009 MRI for tracing living cells Researchers from the Mannheim Medical Faculty which is part of Heidelberg University and the Max Planck Institute MPI for Biological Cybernetics in Tübingen have achieved a world first in the use of magnetic resonance imaging MRI for the simultaneous visualisation of sodium and potassium ions which are important for proper cell function in the living cell. The scientists from the Mannheim Medical Faculty have thus achieved an important milestone…https://www.gesundheitsindustrie-bw.de/en/article/press-release/mri-for-tracing-living-cells
Press release - 22/06/2009 SYGNIS makes further progress in the 2008/2009 fiscal year SYGNIS Pharma AG announced the results of the 2008/2009 fiscal year, which ended on 31 March 2009 and presented the milestones of the reporting period. On the way to becoming a product-based pharmaceutical company specialising in the treatment of disorders of the central nervous system (CNS), SYGNIS has taken further steps forward. One of the key milestones of the reporting period is the completion of the preparations for the multinational phase…https://www.gesundheitsindustrie-bw.de/en/article/press-release/sygnis-makes-further-progress-in-the-2008-2009-fiscal-year
Press release - 22/06/2009 Science2Start: The initial hurdles of company foundation can be overcome In scientists’ heads and desk drawers there exists a mine of dormant ideas that could be turned into commercially successful products according to Dr. Kathrin Ballesteros-Katemann, project manager at BioRegio STERN Management GmbH in Stuttgart. However, a lack of business know-how and the reluctance to take the first step are often major impediments when it comes to becoming self-employed. The Science2Start project now offers such scientists a…https://www.gesundheitsindustrie-bw.de/en/article/press-release/science2start-the-initial-hurdles-of-company-foundation-can-be-overcome
Press release - 22/06/2009 Successful start: cooperative projects of the Rhine-Neckar Biotechnology Cluster (BioRN) The first joint public appearance of the numerous players of the BioRN top cluster underlines the importance of cooperations between industry and science. At the first annual BioRN conference the Cell-based and molecular medicine top cluster announced the successful start of five cooperative projects funded by the German Federal Ministry of Education and Research. In a strategy workshop the companies involved in the projects presented all 36…https://www.gesundheitsindustrie-bw.de/en/article/press-release/successful-start-cooperative-projects-of-the-rhine-neckar-biotechnology-cluster-biorn
Article - 22/06/2009 Scientists with entrepreneurial spirit Dr. Brigitte Angres and Dr. Helmut Wurst have been thinking about establishing their own company for a long time. The Californian biotech company Clontech, where the two scientists worked for several years, will serve as their model now that the two scientists have found an excellent environment for turning their business idea into reality. This environment is the NMI in Reutlingen.https://www.gesundheitsindustrie-bw.de/en/article/news/scientists-with-entrepreneurial-spirit
Article - 15/06/2009 Leena Bruckner-Tuderman – how the skin functions Leena Bruckner-Tuderman from the Department of Dermatology at the University Medical Centre in Freiburg has just been awarded the Eva Luise Köhler Research Prize for Rare Diseases. She has not only made a decisive contribution to the clarification of the molecular causes of the skin disease “dystrophic epidermolysis bullosa”, but has also begun focusing on potential clinical therapies. Prof. Dr. Leena Bruckner-Tuderman from Finland has worked at…https://www.gesundheitsindustrie-bw.de/en/article/news/leena-bruckner-tuderman-how-the-skin-functions
Press release - 10/06/2009 6.56 million euros for first full-body PET-MRI prototype The Joint Science Conference in Bonn has announced that the University of Tübingen will receive 6.56 million euros for the purchase of an entirely new multimodal full-body tomography system for the diagnosis of cancer. The new full-body PET-MRI combines positron emission tomography PET with magnetic resonance imaging MRI in one device.https://www.gesundheitsindustrie-bw.de/en/article/press-release/6-56-million-euros-for-first-full-body-pet-mri-prototype
Article - 10/06/2009 Dirk Linke - a vaccine is ready - just in case There is a well-known saying: travel broadens the mind. This is not the only consequence of travel – the biochemist Dr. Dirk Linke from Tübingen travelled to India on holiday and brought back an idea for a new scientific project. Since his return, his idea, the possibility of developing a vaccine with a wide-ranging effect against some of the most frequent diarrhoea pathogens, has even generated financial backing from prominent supporters.https://www.gesundheitsindustrie-bw.de/en/article/news/dirk-linke-a-vaccine-is-ready-just-in-case
Press release - 10/06/2009 New Research Programme BioInterfaces launched The research center Karlsruhe of the Helmholtz Association and the University of Karlsruhe are represented in the Karlsruhe Institute of Technology. The programme BioInterfaces brings together a team of scientist of several fields to build up a link between science and teachings. 67 research teams develop with an annual budget of approximately 20 Million Euro innovative tools and technologies for precisely controlling the behaviour of cells.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-research-programme-biointerfaces-launched
Article - 10/06/2009 Colleagues who became customers Should they work with a long-standing cooperation partner or should they set up another company that was the decision faced by the staff of the Discovery-IT department of Nycomed formerly ALTANA Pharma in the spring of 2007.https://www.gesundheitsindustrie-bw.de/en/article/news/colleagues-who-became-customers
Press release - 10/06/2009 New tests for and new data about the new influenza type In Germany, test methods that enable the identification of an infection caused by the new influenza A/H1N1 virus, even after the symptoms have subsided or disappeared completely, have become available for the first time. The National Influenza Reference Centre (NRZ) at the Robert Koch Institute has developed two serological tests based on the detection of antibodies in the blood serum. The antibodies are produced about 2 weeks after onset of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-tests-for-and-new-data-about-the-new-influenza-type
Press release - 10/06/2009 University of Ulm to receive Draeger Prize for best publication in 2008 The Hospital of Anaesthesiology at Ulm University has been awarded the Draeger Prize by the European Society for Anaesthesiology for the best publication in the field of intensive care medicine in 2008. The university’s press office explained that the award-winning publication was a report on a two-year project investigating the effects of pure oxygen breathing to treat septic circulatory shock. The prize comes with a cheque of 10,000 euros. https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-of-ulm-to-receive-draeger-prize-for-best-publication-in-2008
Article - 10/06/2009 Student initiative supports intercultural exchange A small work group of eight technical biologists at Stuttgart University has been contributing to international exchange since 2006. Interquer AG is a student-initiated project that has the objective of providing support for the re-integration of national and international guest students as well as transfer students early entrance students and students who return to their studies after a long illness. The Interquer AG students who act as mentors…https://www.gesundheitsindustrie-bw.de/en/article/news/student-initiative-supports-intercultural-exchange
Article - 09/06/2009 We would gladly finance more biotechs For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…https://www.gesundheitsindustrie-bw.de/en/article/news/we-would-gladly-finance-more-biotechs
Press release - 03/06/2009 Hohenstein Institute develops textile that releases medicinal gasses The Institute for Hygiene and Biotechnology (IHB) at Hohenstein has developed the first textile that can release medically effective gasses. The textile was developed at the IHB under the auspices of a broader research project. The textile will be used in future therapeutic applications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hohenstein-institute-develops-textile-that-releases-medicinal-gasses
Article - 03/06/2009 Quality management for biotech companies? What kind of permits and certification do young biotech companies need? Do particular requirements in the quality assurance of production processes based on initial permits still have to be taken into account 10 years after foundation? Ten years on, it may in fact be necessary to obtain different certificates that take external factors into account as well as changes in a company’s product and service portfolio. But what do ISO 9001, ISO 13485,…https://www.gesundheitsindustrie-bw.de/en/article/news/quality-management-for-biotech-companies
Article - 29/05/2009 ITV Denkendorf – Hi-tech think tank for textiles The Institute of Textile Technology and Process Engineering Denkendorf ITV Denkendorf is Germanys largest and oldest textile research centre. Research is carried out in specialised laboratories and technical centres covering the entire range of textiles from raw materials to the final product both in basic as well as applied research. https://www.gesundheitsindustrie-bw.de/en/article/news/itv-denkendorf-hi-tech-think-tank-for-textiles
Press release - 28/05/2009 CONCERT Medical Optics wins special CyberOne prize The company CONCERT Medical Optics was selected from more than 70 participants from all over Germany to receive a special CyberOne prize for the most innovative start-up concept namely a medical instrument called EndoTherapeuthoSkop. This instrument combines different technologies enabling the simultaneous detection and treatment of tumours meaning that patients only have to undergo one rather than several interventions.https://www.gesundheitsindustrie-bw.de/en/article/press-release/concert-medical-optics-wins-special-cyberone-prize
Press release - 28/05/2009 CureVac Begins Clinical Study with mRNA Vaccine CureVac GmbH announced that the Paul-Ehrlich-Institute, the German regulatory authority for medicinal products, has approved the Clinical Trial Application (CTA) to begin a Phase I clinical study with RNActive® derived mRNA vaccine CV9201. The vaccine will be tested in patients with advanced non-small cell lung cancer who have been pre-treated with different therapies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-begins-clinical-study-with-mrna-vaccine
Article - 28/05/2009 Renovation work in the brain Damaged nerves in the brain only grow together again with difficulty. Scar tissue develops at the site of injury rendering the outgrowth of new protrusions almost impossible. Dr. Matthias Kirsch and his team from the Institute of Anatomy and Cell Biology at the University of Freiburg are investigating the role of a signalling molecule that might one day make regeneration possible. This molecule, a cytokine of the interleukin-6 family, influences…https://www.gesundheitsindustrie-bw.de/en/article/news/renovation-work-in-the-brain
Press release - 27/05/2009 REGiNA makes regenerative medicine standard practice in patient care German Federal Minister Annette Schavan announced BioRegio STERN Management GmbH a winner of the Gesundheitsregionen der Zukunft Health Regions of the Future competition on 27 May in Berlin. The German Federal Ministry of Education and Research BMBF will support the planned Users Centre for Regenerative Medicine in the Neckar-Alb and Stuttgart health region REGiNA for the next four years covering around half of the total budget of almost EUR 17…https://www.gesundheitsindustrie-bw.de/en/article/press-release/regina-makes-regenerative-medicine-standard-practice-in-patient-care
Article - 27/05/2009 Raimund Hibst brings laser into dental practices Nowadays, in many dental practices drills are no longer used to remove caries – much to the patients’ delight. Such practices have replaced drills with lasers, a virtually painless method, with low noise levels and which does not require a local anaesthetic. This is all thanks to the work of Raimund Hibst, a physicist from the ILM in Ulm who has spent many years turning research findings into health market applications, in cooperation with…https://www.gesundheitsindustrie-bw.de/en/article/news/raimund-hibst-brings-laser-into-dental-practices
Dossier - 25/05/2009 The different phases of company foundation Founding a company is a very complex process especially in knowledge-intensive sectors such as biotechnology. Turning a vague business idea into a successful company is characterised by different phases that place great demands on the qualifications and learning aptitudes of the company founders. Financing and economic organisation often means that company founders have to enter completely unknown new territory.https://www.gesundheitsindustrie-bw.de/en/article/dossier/the-different-phases-of-company-foundation
Article - 20/05/2009 One-sided diabetes debate – social issues not in the public domain Paediatrician and epidemiologist Reinhard Holl does not like exaggeration. He knows the real statistics only too well and, at the same time, is well aware how different statistics relating to diabetes in children and adolescents are “sold” to the public. Holl is head of the Computer-based Quality Management in Medicine workgroup at the Institute of Epidemiology at the University of Ulm. He has been collecting data on diabetes since 1995 and has…https://www.gesundheitsindustrie-bw.de/en/article/news/one-sided-diabetes-debate-social-issues-not-in-the-public-domain
Article - 19/05/2009 What makes blood vessels sprout? Calcified arteries or capillaries – this is often associated with blood stasis, reduced oxygen supply, and subsequent cardiac strain that compensates these deficiencies. Dr. Sebastian Grundmann from the Department of Cardiology and Angiology at the University Medical Centre Freiburg and his team are investigating how the growth of blood vessels is triggered, and potentially find ways to naturally deviate the site of congestion. https://www.gesundheitsindustrie-bw.de/en/article/news/what-makes-blood-vessels-sprout
Article - 17/05/2009 What is a Mini GmbH? Can life science start-ups use this status? On November 1st 2008, a new law bringing significant change for limited liability companies (German GmbHs) in Germany was put into effect – Law for the Modernisation of the German Liability Company Law and the Prevention of Misuse (MoMiG; Gesetz zur Modernisierung des GmbH-Rechts und zur Bekämpfung von Missbräuchen). Under the new law, the new legal type of GmbH (UG – Unternehmergesellschaft) may be formed with share capital of just €1.…https://www.gesundheitsindustrie-bw.de/en/article/news/what-is-a-mini-gmbh-can-life-science-start-ups-use-this-status
Article - 16/05/2009 Mykotown Greentech AG uses mycorrhiza to keep plants going Mykotown Greentech AG offer mycorrhizal preparations that protect the plants against dehydration and bacteria. The fungi also enhance plant growth. The plants provide the natural soil fungi with carbon while the fungi help the plant to capture nutrients and liquids from the soil.https://www.gesundheitsindustrie-bw.de/en/article/news/mykotown-greentech-ag-uses-mycorrhiza-to-keep-plants-going
Article - 15/05/2009 Diabetes: we cannot wait any longer, we must act now! The renowned endocrinologist Prof. Bernhard Böhm from Ulm, like many of his colleagues, is of the opinion that diabetes is a problem that concerns society as a whole. The following interview with the head of endocrinology at the University Hospital of Ulm shows why the USA invests 50 times more money into diabetes research and Böhm tells us about the three wishes he would ask of a “diabetes fairy”.https://www.gesundheitsindustrie-bw.de/en/article/news/diabetes-we-cannot-wait-any-longer-we-must-act-now
Article - 15/05/2009 Interdisciplinarity starts with support and supervision As new General Manager the all-round talent Dr. Heike Brandstädter has taken the helm of the PhD Graduate School. Through her work at the crossroads of the humanities and natural sciences her particular aim is to lessen the burden on young researchers and increase their chances of success on the job market.https://www.gesundheitsindustrie-bw.de/en/article/news/interdisciplinarity-starts-with-support-and-supervision
Press release - 14/05/2009 Mannheim University of Applied Sciences: scientists to receive start-up grant Dr. Heiko Flammann and Dr. Andreas Lux have received a one-year start-up grant from the German Ministry of Economics and Technology EXIST programme. The two scientists worked for many years at the Institute for Molecular and Cellular Biology (Head: Prof. Dr. Mathias Hafner) in the Faculty of Biotechnology at the Mannheim University of Applied Sciences.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mannheim-university-of-applied-sciences-scientists-to-receive-start-up-grant
Article - 14/05/2009 A multicentred approach for the treatment and prevention of diabetes In order to counteract the increase in the number of diabetics it is necessary to take into account the entire psychosocial environment of the patients states Prof. Dr. Peter Nawroth a physician from Heidelberg University Hospital. The prevention of late complications must be a major goal of any treatment and patient consultation. By focusing on the development and investigation of the RAGE-dependent reaction system Nawroth and his team have…https://www.gesundheitsindustrie-bw.de/en/article/news/a-multicentred-approach-for-the-treatment-and-prevention-of-diabetes
Article - 13/05/2009 Mitochondria – making the impossible possible The transport of proteins across the two mitochondrial membranes is a very complex process. Huge molecular machines recognise the precursor proteins which are formed inside the cell and which are destined for the energy power stations of the cells. Some of these substances pass the outer and the inner membrane, some of them remain in the intermembrane area. How does the sorting of the molecules work? Five years ago, molecular biologist Dr.…https://www.gesundheitsindustrie-bw.de/en/article/news/mitochondria-making-the-impossible-possible
Article - 12/05/2009 Fatal relatives: adiposity and diabetes Martin Wabitsch was the first German pediatrician to investigate adiposity back when it was seen as a strange subject to study. Nowadays, in Germany the attitude towards adiposity has completely changed. More and more people are suffering from adiposity and diabetes and are consequently at risk of contracting other severe diseases as a result. In children and young adults the situation is alarming; many children are at risk of contracting…https://www.gesundheitsindustrie-bw.de/en/article/news/fatal-relatives-adiposity-and-diabetes
Article - 12/05/2009 Islet cell transplantation gives new hope to diabetics Establishing a medical therapy requires a great deal of patience. An interdisciplinary group of researchers at the University Hospital Tübingen knows this from experience. It took more than three years before researchers succeeded in transplanting insulin-producing cells. However, the huge effort has paid off two-fold: the diabetes sufferer feels well after the intervention and secondly, Tübingen became the first German centre to receive the…https://www.gesundheitsindustrie-bw.de/en/article/news/islet-cell-transplantation-gives-new-hope-to-diabetics
Press release - 12/05/2009 Gene variant responsible for defective communication in the brain Schizophrenia and bipolar disorder are psychological diseases that are both common and severe. The causes of these diseases are largely unknown. It has been known for some time that certain hereditary factors enhance the risk of developing schizophrenia or a manic-depressive disorder. Researchers from the ZI in Mannheim and the Department of Medicine Psychology at the University of Bonn have managed to identify the effects of such gene variants…https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-variant-responsible-for-defective-communication-in-the-brain
Press release - 11/05/2009 CellGenix Technologie Transfer GmbH: 15 years of innovation and market leadership 2009 is a very special year for CellGenix a biotechnology company located in Freiburg. The company is celebrating its 15th anniversary - 15 years of innovation and market leadership in the production of high-quality cell therapeutics and growth factors for clinical cell therapy.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cellgenix-technologie-transfer-gmbh-15-years-of-innovation-and-market-leadership
Dossier - 11/05/2009 Diabetes, a danger that is still underestimated In 2010 there will be 10 million diabetes patients in Germany and nearly 33 millions in Europe. The diabetes avalanche is rolling and what is Germany doing? So far so little say experts. There is a lot happening at the same time in different places little is evaluated and a lot is lost in the maelstrom of individual interests. The figures are clear The metabolic disease known as diabetes has reached the proportions of a worldwide epidemic. It not…https://www.gesundheitsindustrie-bw.de/en/article/dossier/diabetes-a-danger-that-is-still-underestimated
Article - 11/05/2009 Metastasis-inducing cancer stem cells Just a small subpopulation of cancer cells namely metastasis-inducing cancer stem cells MICs is potentially responsible for the formation of distant malignant tumour metastases. The characterisation of MICs and the clarification of mechanisms that lead to their reactivation from a dormant state opens up new strategies for the development of new effective therapies against metastasising tumours.https://www.gesundheitsindustrie-bw.de/en/article/news/metastasis-inducing-cancer-stem-cells
Article - 11/05/2009 Can stem cells treat diabetes? Stem cells are seen as the miracle cure of the future for many degenerative diseases. Scientists and physicians also hope that stem cells will exert their regenerative effect in the treatment of diabetes type 1 which is caused by damaged tissue. https://www.gesundheitsindustrie-bw.de/en/article/news/can-stem-cells-treat-diabetes
Article - 11/05/2009 Biopolymers to improve drinking water quality In the long run, biopolymers will find their way into industry and everyday life; they are the polymers of the future. The Institute for Sanitary Engineering, Water Quality and Solid Waste Management at the University of Stuttgart offers applications of biopolymers for the preparation of water as well as a new recycling strategy.https://www.gesundheitsindustrie-bw.de/en/article/news/biopolymers-to-improve-drinking-water-quality
Article - 04/05/2009 Perikles Simon – more than just hunting down the dope cheats Whether it be the Olympic Games world championships or the Tour de France whenever a big sports event is coming up Dr. Dr. Perikles Simon from the University Hospital of Tübingen is a sought-after interviewee for the media. Simon has developed a test which may eventually help detect the latest performance-enhancing method gene doping.https://www.gesundheitsindustrie-bw.de/en/article/news/perikles-simon-more-than-just-hunting-down-the-dope-cheats
Press release - 01/05/2009 They have the super cell In the Year of Science which is being celebrated in the city of Constance in 2009 the company Trenzyme located in the Constance industrial park is a prime example of science and industry working successfully hand in hand on the Nycomed campus.https://www.gesundheitsindustrie-bw.de/en/article/press-release/they-have-the-super-cell
Press release - 01/05/2009 Gaining insights into potato cells Viruses and bacteria are the lifeblood of GATC a family-run biotechnology company that is continuing to grow in spite of the current economic downturn. At the moment GATC is working on the sequence of one particular vegetable - and the company has submitted a building application to add another 1000 square metres to the existing 800.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gaining-insights-into-potato-cells
Press release - 30/04/2009 Prize for more efficient radiotherapy for leukaemia Peter Kletting’s model can be used to irradiate the tumour cells of leukaemia patients more accurately, reduce potential side effects and increase the chances of therapeutic success. The scientist from the Department of Nuclear Medicine at the University Hospital of Ulm has been awarded the Society for Nuclear Medicine Covidien Award that comes with a purse of 7,500 euros. https://www.gesundheitsindustrie-bw.de/en/article/press-release/prize-for-more-efficient-radiotherapy-for-leukaemia